Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cancer treatment communications
| Cancer treatment communications |
| Pubbl/distr/stampa | [Amsterdam] : , : Elsevier, , [2013-2016] |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.99/4 |
| Soggetto topico |
Cancer - Treatment
Neoplasms Medical Oncology |
| Soggetto genere / forma |
Periodicals.
Periodical |
| Soggetto non controllato | Oncology |
| ISSN | 2213-0896 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910231757403321 |
| [Amsterdam] : , : Elsevier, , [2013-2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer treatment reviews
| Cancer treatment reviews |
| Pubbl/distr/stampa | [London], : W.B. Saunders |
| Disciplina | 616 |
| Soggetto topico |
Cancer - Treatment
Cancer Neoplasms - therapy Cancer - Traitement |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| ISSN | 1532-1967 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996205863303316 |
| [London], : W.B. Saunders | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Cancer treatment reviews
| Cancer treatment reviews |
| Pubbl/distr/stampa | [London], : W.B. Saunders |
| Disciplina | 616 |
| Soggetto topico |
Cancer - Treatment
Cancer Neoplasms - therapy Cancer - Traitement |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| ISSN | 1532-1967 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910333250603321 |
| [London], : W.B. Saunders | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Treatment: An Interdisciplinary Approach [[electronic resource] /] / edited by Nima Rezaei
| Cancer Treatment: An Interdisciplinary Approach [[electronic resource] /] / edited by Nima Rezaei |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (XIII, 426 p. 67 illus., 60 illus. in color.) |
| Disciplina | 616.994 |
| Collana | Interdisciplinary Cancer Research |
| Soggetto topico |
Cancer - Treatment
Cancer Tumors - Immunological aspects Stem cells Oncology Neoplasms - therapy Immunotherapy Stem Cells Cancer Therapy Cancer Biology Tumour Immunology Cancer Stem Cells |
| ISBN | 3-031-43983-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cancer: A Complex Problem Requiring Interdisciplinary Research -- Tumor Immunology and Immunotherapy -- New Approaches Targeting Immuno-oncology and Tumor Microenvironment -- Tumor Infiltrating Lymphocytes as Markers of the Antitumor Therapy Efficacy: Myth or Reality? -- Recent Innovative Approaches to Intensify the Efficacy and Safety of CAR-T Cell Therapy in Cancers -- An Updated Focus on Immune Checkpoint Inhibitors and Tubulointerstitial Nephritis -- Cancer Stem Cell as a Target for Immunotherapeutic Approach -- Immunological Properties of Manipulated Hematopoietic Stem Cell Grafts -- Recent Development of Quinoline Derivatives as Anticancer Agents: 2015-2022 -- Antitumor Immunotherapy: Effect of COVID-19 in Cancer Patients -- The Use of Immunotherapy in Cancer Patients with Autoimmune Diseases -- The Effects of Low-dose Non-ionizing and Ionizing Radiation on Wound Healing and Cancer -- How Is Cancer Under the Sea? Hyperbaric Oxygen Therapy in Cancer -- Interventional Oncology Techniques: A Primer for Non-Users -- Future Perspectives of Phytochemicals in Cancer Therapy -- Integrated Palliative Cancer Care: From an Interdisciplinary Perspective -- Correction to: Cancer: A Complex Problem Requiring Interdisciplinary Research. |
| Record Nr. | UNINA-9910799499503321 |
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer trends progress report [[electronic resource] /] / National Cancer Institute
| Cancer trends progress report [[electronic resource] /] / National Cancer Institute |
| Pubbl/distr/stampa | Bethesda, MD, : National Cancer Institute, NIH, DHHS, 2005- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Cancer - Research - United States
Cancer - Treatment - United States Cancer - United States - Prevention Neoplasms - therapy Neoplasms - prevention & control Cancer - Prevention Cancer - Research Cancer - Treatment |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910691302203321 |
| Bethesda, MD, : National Cancer Institute, NIH, DHHS, 2005- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer weekly
| Cancer weekly |
| Pubbl/distr/stampa | Atlanta, GA, : NewsRx.com |
| Disciplina | 616 |
| Soggetto topico |
Cancer - Research
Cancer - Treatment Antineoplastic agents Cancer - Biotechnology |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1532-4567 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996200575803316 |
| Atlanta, GA, : NewsRx.com | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Cannabis and cannabinoid-based medicines in cancer care : a comprehensive guide to medical management / / Claude Cyr [and three others]
| Cannabis and cannabinoid-based medicines in cancer care : a comprehensive guide to medical management / / Claude Cyr [and three others] |
| Autore | Cyr Claude <1957-> |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (325 pages) : illustrations |
| Disciplina | 616.99406 |
| Soggetto topico |
Cancer - Alternative treatment
Cancer - Treatment |
| ISBN | 3-030-89918-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Acknowledgments -- About the Book -- Terminology Used in this Textbook -- Contents -- List of Figures -- List of Tables -- Contributors -- Chapter 1: Overview of the Endocannabinoid System and Endocannabinoidome -- 1.1 Introduction -- 1.2 Terminology -- 1.3 The Canonical Cannabinoid Receptors: CB1 and CB2 -- 1.4 Heterodimers and Membrane Influences on Canonical Cannabinoid Signaling -- 1.5 Constitutive Activation of Canonical Receptors -- 1.6 Allosteric Modulation -- 1.7 Canonical Cannabinoid Receptor Locations -- 1.8 Neurophysiology of Canonical Receptor Activation -- 1.9 Orphan Receptors -- 1.10 Endocannabinoid Ion Channels: Transient Receptor Potential Channels -- 1.11 Interactions Between the Endocannabinoid and Endogenous Opioid Systems -- 1.12 N-Methyl-D-aspartate Receptors and Cannabinoids -- 1.13 Cannabinoid Ligands -- 1.14 Synthesis and Catabolism of Anandamide (AEA) -- 1.15 Synthesis and Catabolism of 2-Arachidonoyl Glycerol (2-AG) -- 1.16 Tetrahydrocannabinol -- 1.17 Tetrahydrocannabinol and the Eicosanoid System -- 1.18 Intracellular Binding Proteins -- 1.19 Phytocannabinoids and P-Glycoprotein and Multidrug Transports -- 1.20 N-Acylethanolamines -- 1.21 Conclusion -- References -- Chapter 2: Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- 2.1 Introduction -- 2.2 Terminology -- 2.3 Endocannabinoids and Drug Interactions -- 2.4 Endocannabinoids, Cyclooxygenase, and Drug Interactions -- 2.5 Endocannabinoids and Glucocorticoids -- 2.6 Endocannabinoids and Opioids -- 2.7 Clinical and Animal Studies of Cannabinoid Opioid Interactions -- 2.8 Endocannabinoids, Anxiety and Depression -- 2.8.1 Endocannabinoid "Tone": Beyond the Theory -- 2.9 Endocannabinoids and Post-traumatic Stress Disorder -- 2.10 Endocannabinoid System Disruptions and Potential Impact on Treatment with Antipsychotics.
2.11 The use of Phytoannabinoids as Antipsychotics -- 2.12 Omega-3 Fatty Acids and effects on the Endocannabinoid System -- 2.13 Phytocannabinoid Pharmacokinetics: THC -- 2.14 Phytocannabinoid Pharmacokinetics: CBD -- 2.15 Cannabidiol and Efflux Pumps -- 2.16 Pharmacokinetics of Approved Cannabinoids -- 2.17 Pharmacokinetic Cannabis-Drug Interactions -- 2.18 Pharmacokinetic Cannabis-Drug Interactions: Relevant Examples -- 2.18.1 Corticosteroids -- 2.18.2 Nonsteroidal Anti-inflammatory Drugs -- 2.18.3 Opioids -- 2.18.4 Antidepressants -- 2.18.5 Janus Kinase Inhibitors -- 2.18.6 Antipsychotics -- 2.18.7 Anticonvulsants -- 2.18.8 Benzodiazepines -- 2.18.9 Ethanol -- 2.18.10 Anticoagulants -- 2.18.11 Antiplatelet Medications -- 2.18.12 HIV Medications -- 2.18.13 Theophylline -- 2.18.14 Chemotherapy -- 2.19 Conclusion -- References -- Chapter 3: Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- 3.1 Introduction -- 3.2 Terminology -- 3.3 Part 1: Synthetic Cannabinoids -- 3.3.1 Synthetic Cannabinoid Use in the Community -- 3.3.2 Pharmacology -- 3.3.2.1 Pharmacodynamics of Synthetic Cannabinoids -- 3.3.2.2 Potential Uses of Synthetic Cannabinoids: Anticancer Activity -- 3.3.2.3 Synthetic Cannabinoid Toxicity -- 3.3.2.4 Withdrawal -- 3.3.3 Conclusion -- 3.4 Part 2: Palmitoylethanolamide (PEA) and the Role of Future Endocannabinoid Modulators in Cancer Care -- 3.4.1 Pharmacodynamics -- 3.4.2 Pharmacokinetics -- 3.4.3 Safety -- 3.5 Conclusion -- References (Synthetic Cannabinoids) -- References (Palmitoylethanolamide Pharmacology Efficacy and Safety) -- Chapter 4: Cannabinoid-Based Medicines as Cancer Therapy -- 4.1 Introduction -- 4.2 Terminology -- 4.3 Antineoplastic Activity of Different Cannabis Formulations -- 4.4 Cannabinoids and Graft Versus Host Disease -- 4.5 Cannabinoids and Immune Checkpoint Inhibitors. 4.6 Using High-Dose Cannabinoids to Treat Cancer (Phoenix Tears/Rick Simpson Oil) -- 4.7 Hail Mary Pass -- 4.8 Conclusion -- References -- Chapter 5: Cannabinoid-Based Medicines and Cancer Symptom Management -- 5.1 Introduction -- 5.2 Terminology -- 5.3 Chemotherapy-Induced Nausea and Vomiting -- 5.4 Appetite Stimulation -- 5.5 Pain -- 5.6 Sleep -- 5.7 Drug-Sparing Effects -- 5.8 Topical Applications for Wound Healing and Analgesia -- 5.9 Multimodal Symptom Treatment in Advanced Cancer -- 5.10 Conclusion -- References -- Chapter 6: Patient Evaluation: Precautions and Managing Expectations -- 6.1 Introduction -- 6.2 Terminology -- 6.3 General Considerations -- 6.4 Risks of Cannabis Use -- 6.5 Potential Increased Cancer Risk with Cannabis Use -- 6.6 Contraindications and Precautions -- 6.7 Managing Physician Expectations -- 6.8 Managing Patient Expectations -- 6.9 Patient Evaluation -- 6.10 The Initial Interview: Key Clinical Questions and Commentary -- 6.11 Detailed Medical History -- 6.11.1 Neurological Effects and Driving Performance -- 6.11.2 Cardiovascular Effects -- 6.11.3 Pulmonary Effects -- 6.11.4 Gastrointestinal Effects -- 6.11.5 Immune System Modulatory Effects -- 6.12 Detailed Psychiatric History -- 6.12.1 Screening for Clinical High Risk for Psychosis (CHR) -- 6.12.2 Possible Protective Effects of CBD in THC-Induced Psychotic-Like Symptoms -- 6.12.3 Anxiety and Depression -- 6.12.4 Bipolar Disease -- 6.12.5 Post-traumatic Stress Disorder -- 6.12.6 Addiction Issues -- 6.12.7 Tolerance -- 6.12.8 Use of Cannabis in Mild Cognitive Impairment or Dementia -- 6.13 Dealing with Trauma-Sensitive Patients -- 6.14 Medication History -- 6.15 Cannabis History -- 6.16 Conclusion -- References -- Chapter 7: Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- 7.1 Introduction. 7.2 Terminology -- 7.3 General Considerations -- 7.4 Review of the Principal Active Ingredients of Cannabis -- 7.4.1 CBD -- 7.4.2 THC -- 7.4.3 THCA, CBDA, and Other Secondary Cannabinoids -- 7.5 Overview of the Main Routes of Administration of Cannabis Products -- 7.5.1 Oral Ingestion -- 7.5.2 Oromucosal Ingestion -- 7.5.3 Inhalation -- 7.5.3.1 Inhalation Techniques (Smoke or Vapor) -- 7.5.3.2 Current Challenges for Calculating a Precise Dose of THC Using Dried Cannabis for Inhalation -- 7.5.4 Topical and Transdermal -- 7.5.5 Intra-rectal and Vaginal (Suppositories) -- 7.6 Considering the Initial Use of Approved Pharmaceutical Cannabinoids -- 7.7 Choosing a Cannabis Formulation -- 7.7.1 Word of Caution on Product Labeling -- 7.7.2 Regarding the Therapeutic Dose of THC -- 7.7.3 Regarding the Protective Effects of CBD on THC Psychoactivity -- 7.8 Cannabinoid Metabolism: Clinical Considerations Between Inhaled and Oral Routes of Administration -- 7.9 Treatment Selection According to Symptom or Clinical Setting -- 7.10 Precise Dosing Recommendations -- 7.10.1 Initial CBD Dosing -- 7.10.2 Initial THC Dosing -- 7.10.3 Considering Microgram THC Dosing -- 7.10.4 Proposed Dosing Protocols from Consensus Groups -- 7.10.5 Considering the Toxic Psychosis Threshold of THC -- 7.10.6 Considering the Use of High-Potency Extracts (Rick Simpson Oil, RSO, Phoenix Tears) -- 7.11 Dealing with Hospitalized Patients Already Taking Cannabinoid-Based Medicines -- 7.12 Estimating the Dose of THC in Unsupervised Patients -- 7.13 Patient Monitoring, Record Keeping, and Follow-Up Visits -- 7.13.1 Reporting Cannabis Side Effects -- 7.14 Overview of Cannabis Use Disorder and Cannabis Withdrawal Syndrome -- 7.15 Conclusion -- 7.16 Chapter Summary -- References -- Chapter 8: Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry -- 8.1 Introduction. 8.2 Terminology -- 8.3 Cannabis Psychoactivity: Current Challenges -- 8.3.1 The Complicated Social, Cultural, and Spiritual History of Cannabis Psychoactivity -- 8.3.2 The Evidence Remains Mostly Anecdotal -- 8.3.3 Our Understanding of the Neurocognitive Effects of THC Has Only Just Begun -- 8.3.4 Management Guidelines for Cannabis Psychoactivity Are Not Available -- 8.3.5 Cannabis Psychoactivity Is Common in Medical Cannabis Patients -- 8.3.6 Avoiding Psychoactivity Is Possible, but Difficult...for Now -- 8.3.7 Precise Dosing Guidelines Are Only Beginning to Emerge -- 8.3.8 Prior Experience with Cannabis May Influence Tolerance to Psychoactivity and Even Psychotic-Like Reactions -- 8.4 Basic Precautions -- 8.4.1 Introducing Cannabis Early in the Course of Life-Limiting Illnesses -- 8.4.2 Preventing Involuntary Intoxications -- 8.4.3 Low Initial THC Dosing: The Cornerstone of Harm Reduction -- 8.4.4 Route of Administration: Oral Versus Inhaled -- 8.5 Preparing Patients for Cannabis Psychoactivity -- 8.5.1 Set and Setting -- 8.5.2 Integration -- 8.5.3 Trauma Sensitivity -- 8.6 Dealing with an Involuntary Intoxication (Bad Trip) -- 8.7 Overview of the Specific Neurocognitive Effects Associated with Cannabis Psychoactivity -- 8.7.1 Slowed Down Perception of Time -- 8.7.2 Metacognition: Thinking About Thinking -- 8.7.3 Metacognition Versus Mind Wandering -- 8.7.4 Metacognition Versus Insight -- 8.7.5 Introspective and Mystical/Spiritual Reflections -- 8.7.6 Reduced Working Memory and Divided Attention -- 8.7.7 Heightened Sense of Awareness and Nonspecific Amplification: The Effects of THC on the Triad Network - Default Mode, Salience, and Central Executive -- 8.7.7.1 The Default Mode Network (DMN) -- 8.7.7.2 The Central Executive Network (CEN) -- 8.7.7.3 The Salience Network (SN) -- 8.7.7.4 Psychotomimetic Properties of THC: The Aberrant Salience Model. 8.7.8 Aversive Memory Extinction. |
| Record Nr. | UNINA-9910544855803321 |
Cyr Claude <1957->
|
||
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiotoxicity of Oncologic Treatments / / edited by Manuela Fiuza
| Cardiotoxicity of Oncologic Treatments / / edited by Manuela Fiuza |
| Pubbl/distr/stampa | Rijeka : , : InTech, , 2012 |
| Descrizione fisica | 1 online resource (xi, 196 pages) : illustrations |
| Disciplina | 616.99406 |
| Soggetto topico | Cancer - Treatment |
| ISBN | 953-51-6893-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910138252303321 |
| Rijeka : , : InTech, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Caring for patients across the cancer care continuum : essentials for primary care / / Larissa Nekhlyudov [and four others], editors
| Caring for patients across the cancer care continuum : essentials for primary care / / Larissa Nekhlyudov [and four others], editors |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2019] |
| Descrizione fisica | 1 online resource (ix, 204 pages) |
| Disciplina | 616.994075 |
| Collana | Gale eBooks |
| Soggetto topico |
Cancer - Diagnosis
Cancer - Patients - Care Cancer - Treatment |
| ISBN | 3-030-01896-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction and Overview -- Cancer Prevention -- Cancer Screening -- Cancer Diagnosis -- Cancer Treatment -- Cancer Survivorship -- Palliative Care/End-of-Life Care. |
| Record Nr. | UNINA-9910337519203321 |
| Cham, Switzerland : , : Springer, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
El cáncer [[electronic resource] ] : preguntas y respuestas
| El cáncer [[electronic resource] ] : preguntas y respuestas |
| Pubbl/distr/stampa | [Bethesda, Md.] : , : National Cancer Institute, , [2005] |
| Descrizione fisica | 8 pages : digital, PDF file |
| Collana | Hojas informativas |
| Soggetto topico | Cancer - Treatment |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | spa |
| Altri titoli varianti | Cáncer |
| Record Nr. | UNINA-9910697339803321 |
| [Bethesda, Md.] : , : National Cancer Institute, , [2005] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Cancer - Treatment
(391)
- Cancer (51)
- Neoplasms - therapy (47)
- Neoplasms (40)
- Oncology (36)